An unexpected twist in alopecia areata pathogenesis: Are NK cells protective and CD49b+ T cells pathogenic?

Experimental Dermatology

Volumn 19, Issue 8, 2010, Pages

  Kaufman, Gil ^a   d'Ovidio, Roberto ^b   Kaldawy, Anis ^a   Assy, Bedia ^a   Ullmann, Yehuda ^a   Etzioni, Amos ^a   Paus, Ralf ^c,d   Gilhar, Amos ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b Associazione Italiana Dermatologi Ambulatoriali   (Italy)

^c UNIVERSITY OF LÜBECK   (Germany)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Alopecia Areata; Autoimmunity; CD49b+ cells; NK cells

Indexed keywords

GAMMA INTERFERON;

ALOPECIA AREATA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CD49B+ T LYMPHOCYTE; CELL COUNT; CELL FUNCTION; CELL INFILTRATION; CELL PROTECTION; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; HAIR LOSS; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LETTER; MOUSE; NATURAL KILLER CELL; NONHUMAN; PATHOGENESIS; T CELL DEPLETION; T LYMPHOCYTE;

ALOPECIA AREATA; ANIMALS; ANTIBODIES, ANTI-IDIOTYPIC; DISEASE MODELS, ANIMAL; FEMALE; INJECTIONS; INTEGRIN ALPHA2; KILLER CELLS, NATURAL; MICE; MICE, INBRED C3H; T-LYMPHOCYTES;

EID: 77954848269     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2010.01106.x     Document Type: Letter

References (30)

1. Gilhar A, Paus R, Kalish R S. J Clin Invest 2007, 117:2019-2027.
2. Paus R, Nickoloff B J, Ito T. Trends Immunol 2005, 26:32-40.
3. Ito T, Ito N, Bettemann A, Tokura Y, Takigawa M, Paus R. Am J Pathol 2004, 164:623-634.
4. Gilhar A, Ullmann Y, Berkutzki T, Assy B, Kalish R S. J Clin Invest 1998, 101:62-67.
5. Paus R, Slominski A, Czarnetzki B M. Yale J Biol Med 1993, 66:541-554.
6. Ruckert R, Hofmann U, Van der Veen C, Bulfone-Paus S, Paus R. J Invest Dermatol 1998, 111:25-30.
7. Freyschmidt-Paul P, McEIee K J, Hoffmann R. Br J Dermatol 2006, 155:515-521.
8. Gasser S, Raulet D H. Immunol Rev 2006, 214:130-142.
9. Christoph T, Müller-Röver S, Audring H. Br J Dermatol 2000, 142:862-873.
10. Ito T, Ito N, Saatoff M. J Invest Dermatol 2008, 128:1196-1206.
11. Sundberg J P, Cordy W R, King L E. J Invest Dermatol 1994, 102:847-856.
12. Sundberg J P, Boggess D, Silva K A. J Invest Dermatol 2003, 120:771-775.
13. McElwee K J, Boggess D, King L E, Sundberg J P. J Invest Dermatol 1998, 111:797.
14. Sun J, Silva K A, McElwee K J, King L E, Sundberg J P. Exp Dermatol 2008, 17:793-805.
15. Winkler-Pickett R, Winkler-Pickett R, Young H A. J Immunol 2008, 180:4495-4506.
16. Sivori S, Vitale M, Morelli L. J Exp Med 1997, 186:1129-1136.
17. Pellicci D G, Hammond K J, Coquet J. J Immunol 2005, 142:862-873.
18. Stenström M, Sköld M, Ericsson A. Eur J Immunol 2004, 34:56-65.
19. Sasaki K, Tsuji T, Jinushi T. Int Immunol 2003, 15:701-710.
20. Schepis D, Gunnarsson I, Eloranta M L. Immunology 2009, 126:140-146.
21. Dobrzanski M J, Reome J B, Hylind J C, Rewers-Felkins K A, Abdulsamad K, Adams S L. Immunol Invest 2008, 37:315-338.
22. Rahmoun M, Foussat A, Groux H, Pène J, Yssel H, Chanez P. Int Arch Allergy Immunol 2006, 140:139-149.
23. Knedla A, Riepl B, Lefevre S. Ann Rheum Dis 2009, 68:124-129.
24. Xu W, Fazekas G, Hara H, Tabira T. J Neuroimmunol 2005, 163:24-30.
25. Zhang B, Yamamura T, Kondo T. J Exp Med 1997, 186:1677-1687.
26. Kitaichi N, Kotake S, Morohashi T. J Leukoc Biol 2002, 72:1117-1121.
27. Han W G, Schuurhuis D H, Fu N. Eur J Immunol 2009, 39:1765-1773.
28. Charbonnier L M, van Duivenvoorde L M, Apparailly F. J Immunol 2006, 177:3806-3813.
29. Kassiotis G, Gray D, Kiafard Z, Zwirner J, Stockinger B. J Immunol 2006, 177:968-975.
30. Zöller M, McElwee K J, Vitacolonna M, Hoffmann R. Exp Dermatol 2004, 13:435-444.